2-Amino-1-[4-(3,4-dichlorophenoxy)-piperidine-1-yl]-3-methyl-butan-1-one → 1-[4-(3,4-Dichlorophenoxy)-piperidin-1-ylmethyl]-2-methyl-propylamine

HRID 496883Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 496883
[NH2:1][CH:2]([CH:20]([CH3:22])[CH3:21])[C:3]([N:5]1[CH2:10][CH2:9][CH:8]([O:11][C:12]2[CH:17]=[CH:16][C:15]([Cl:18])=[C:14]([Cl:19])[CH:13]=2)[CH2:7][CH2:6]1)=O>C1COCC1>[Cl:19][C:14]1[CH:13]=[C:12]([CH:17]=[CH:16][C:15]=1[Cl:18])[O:11][CH:8]1[CH2:7][CH2:6][N:5]([CH2:3][CH:2]([NH2:1])[CH:20]([CH3:21])[CH3:22])[CH2:10][CH2:9]1

Komponenten

3

Reaktionsbedingungen

Temperatur
70 °C

Versuchsvorschrift

The product of step (ii) (1.12 g) was dissolved in THF (10 ml) and Borane/THF complex (22.7 ml) added. The mixture was heated under reflux for 2 hours and cooled. The solvent was evaporated, the product dissolved in methanol (5 ml) and 50% aqueous HCl solution added. The mixture was heated to 70° C. for 1 hour and cooled to room temperature. The solvent was removed, ethyl acetate and 2N aqueous NaOH solution were added to give pH 9.0. The organic phase was separated and the solvent evaporated to give the sub-titled compound as an oil (0.98 g) which used without further purification.

Aufarbeitung

  1. additionBorane/THF complex (22.7 ml) added
  2. temperatureThe mixture was heated
  3. temperatureunder reflux for 2 hours
  4. temperaturecooled
  5. customThe solvent was evaporated
  6. dissolutionthe product dissolved in methanol (5 ml)
  7. addition50% aqueous HCl solution added
  8. temperaturecooled to room temperature
  9. customThe solvent was removed
  10. additionethyl acetate and 2N aqueous NaOH solution were added
  11. customto give pH 9.0
  12. customThe organic phase was separated
  13. customthe solvent evaporated

Quellen und Nachweise

ORD-Eintrag
ord-3ca421c901c242289dc465b17f7c8c6f
Quelldatensatz
uspto-grants-2005_09
Patentnummer
US06946478B2

Notizen zur Reaktion

Wird geladen…